(Alliance News) - Astrazeneca on Friday hailed positive results from a phase-three trial of its asthma treatment breztri aerosphere. Shares in the Cambridge, England-based pharmaceutical company rose ...
The FDA delays approval AstraZeneca lupus drug Saphnelo for subcutaneous use, pending additional data; intravenous form remains available globally.
Calgary Herald on MSN
Fatality inquiry hears of link between deadly disorder and AstraZeneca COVID vaccine
The natural disorder which killed an otherwise healthy Calgary man months after he was vaccinated against COVID-19 could be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results